Reader Response: SARS-CoV-2 Vaccination Safety in Guillain-Barré Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy, and Multifocal Motor Neuropathy
- PMID: 37400257
- PMCID: PMC10351317
- DOI: 10.1212/WNL.0000000000207542
Reader Response: SARS-CoV-2 Vaccination Safety in Guillain-Barré Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy, and Multifocal Motor Neuropathy
Comment in
-
Author Response: SARS-CoV-2 Vaccination Safety in Guillain-Barré Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy, and Multifocal Motor Neuropathy.Neurology. 2023 Jul 4;101(1):51. doi: 10.1212/WNL.0000000000207541. Neurology. 2023. PMID: 37400258 Free PMC article. No abstract available.
Comment on
-
SARS-CoV-2 Vaccination Safety in Guillain-Barré Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy, and Multifocal Motor Neuropathy.Neurology. 2023 Jan 10;100(2):e182-e191. doi: 10.1212/WNL.0000000000201376. Epub 2022 Sep 20. Neurology. 2023. PMID: 36127144
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous